1. Home
  2. KZIA vs MGOL Comparison

KZIA vs MGOL Comparison

Compare KZIA & MGOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • MGOL
  • Stock Information
  • Founded
  • KZIA 1994
  • MGOL 2018
  • Country
  • KZIA Australia
  • MGOL United States
  • Employees
  • KZIA N/A
  • MGOL N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • MGOL Advertising
  • Sector
  • KZIA Health Care
  • MGOL Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • MGOL Nasdaq
  • Market Cap
  • KZIA 6.0M
  • MGOL 1.1M
  • IPO Year
  • KZIA 1999
  • MGOL 2023
  • Fundamental
  • Price
  • KZIA $0.89
  • MGOL $0.72
  • Analyst Decision
  • KZIA Strong Buy
  • MGOL
  • Analyst Count
  • KZIA 2
  • MGOL 0
  • Target Price
  • KZIA $11.50
  • MGOL N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • MGOL 176.5M
  • Earning Date
  • KZIA 03-26-2025
  • MGOL 03-31-2025
  • Dividend Yield
  • KZIA N/A
  • MGOL N/A
  • EPS Growth
  • KZIA N/A
  • MGOL N/A
  • EPS
  • KZIA N/A
  • MGOL N/A
  • Revenue
  • KZIA $1,655,324.00
  • MGOL $5,197,527.00
  • Revenue This Year
  • KZIA $806.89
  • MGOL N/A
  • Revenue Next Year
  • KZIA N/A
  • MGOL N/A
  • P/E Ratio
  • KZIA N/A
  • MGOL N/A
  • Revenue Growth
  • KZIA 248000.00
  • MGOL 47.01
  • 52 Week Low
  • KZIA $0.89
  • MGOL $0.10
  • 52 Week High
  • KZIA $15.80
  • MGOL $18.30
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 28.96
  • MGOL 55.59
  • Support Level
  • KZIA $0.90
  • MGOL $0.43
  • Resistance Level
  • KZIA $1.60
  • MGOL $0.76
  • Average True Range (ATR)
  • KZIA 0.24
  • MGOL 0.14
  • MACD
  • KZIA 0.01
  • MGOL 0.11
  • Stochastic Oscillator
  • KZIA 0.00
  • MGOL 53.25

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About MGOL MGO Global Inc.

MGO Global Inc has built a brand acceleration platform with a focus on the acquisition, optimization and monetization of consumer brands across multiple categories. Its mission is to provide customers with unmatched variety, quality and shopping experience. The Company has three reportable segments: 1) The Messi Store, which sells a range of products under The Messi Brand; 2) Stand Flagpoles, which sells a range of residential flagpoles and related products direct to consumers; and 3) Corporate, which generates no revenue, but reflects corporate expenses related primarily to being a public company.

Share on Social Networks: